Cite
APA Citation
Wen, P., Cloughesy, T., de Groot, J., Battiste, J., Garner, J., Simpson, J., Olivero, A., & Gerstner, E. (n.d.). aCTR-51. PHASE 2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND CLINICAL ACTIVITY OF PI3K/MTOR INHIBITOR GDC-0084 GIVEN TO GLIOBLASTOMA (GBM) PATIENTS WITH UNMETHYLATED O6-METHYLGUANINE-METHYLTRANSFERASE PROMOTER STATUS. Neuro-oncology, 20, vi23. http://access.bl.uk/ark:/81055/vdc_100095508705.0x000012